Cargando…
Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing.
A cytotoxicity assay was used to study the action of bacillus Calmette-Guerin (BCG) and cytokines on four human bladder cancer cell lines. Monocytes and lymphocytes from peripheral blood were incubated with or without BCG or cytokines for 24 h, after which [3H]thymidine-labelled target cells were ad...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033737/ https://www.ncbi.nlm.nih.gov/pubmed/7710947 |
_version_ | 1782136903016906752 |
---|---|
author | Pryor, K. Goddard, J. Goldstein, D. Stricker, P. Russell, P. Golovsky, D. Penny, R. |
author_facet | Pryor, K. Goddard, J. Goldstein, D. Stricker, P. Russell, P. Golovsky, D. Penny, R. |
author_sort | Pryor, K. |
collection | PubMed |
description | A cytotoxicity assay was used to study the action of bacillus Calmette-Guerin (BCG) and cytokines on four human bladder cancer cell lines. Monocytes and lymphocytes from peripheral blood were incubated with or without BCG or cytokines for 24 h, after which [3H]thymidine-labelled target cells were added and the 72 h percentage specific release determined. BCG had a direct cytotoxic effect against tumour cells and significantly enhanced monocyte/macrophage and enhanced lymphocyte cytotoxicity against one cell line (UCRU-BL-17). Supernatants (SNs) from BCG-activated monocytes/macrophages and lymphocytes increased the percentage specific release of [3H]thymidine from UCRU-BL-17 cells. Interferon alpha (IFN-alpha) and interleukin 2 (IL-2) were cytotoxic towards UCRU-BL-17. No synergy occurred between BCG and cytokines at the concentrations tested. The results suggest that BCG is superior to IFN-alpha, interferon gamma (IFN-gamma) and IL-2 in enhancing cell-mediated cytotoxicity. |
format | Text |
id | pubmed-2033737 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1995 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-20337372009-09-10 Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing. Pryor, K. Goddard, J. Goldstein, D. Stricker, P. Russell, P. Golovsky, D. Penny, R. Br J Cancer Research Article A cytotoxicity assay was used to study the action of bacillus Calmette-Guerin (BCG) and cytokines on four human bladder cancer cell lines. Monocytes and lymphocytes from peripheral blood were incubated with or without BCG or cytokines for 24 h, after which [3H]thymidine-labelled target cells were added and the 72 h percentage specific release determined. BCG had a direct cytotoxic effect against tumour cells and significantly enhanced monocyte/macrophage and enhanced lymphocyte cytotoxicity against one cell line (UCRU-BL-17). Supernatants (SNs) from BCG-activated monocytes/macrophages and lymphocytes increased the percentage specific release of [3H]thymidine from UCRU-BL-17 cells. Interferon alpha (IFN-alpha) and interleukin 2 (IL-2) were cytotoxic towards UCRU-BL-17. No synergy occurred between BCG and cytokines at the concentrations tested. The results suggest that BCG is superior to IFN-alpha, interferon gamma (IFN-gamma) and IL-2 in enhancing cell-mediated cytotoxicity. Nature Publishing Group 1995-04 /pmc/articles/PMC2033737/ /pubmed/7710947 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Pryor, K. Goddard, J. Goldstein, D. Stricker, P. Russell, P. Golovsky, D. Penny, R. Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing. |
title | Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing. |
title_full | Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing. |
title_fullStr | Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing. |
title_full_unstemmed | Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing. |
title_short | Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing. |
title_sort | bacillus calmette-guerin (bcg) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033737/ https://www.ncbi.nlm.nih.gov/pubmed/7710947 |
work_keys_str_mv | AT pryork bacilluscalmetteguerinbcgenhancesmonocyteandlymphocytemediatedbladdertumourcellkilling AT goddardj bacilluscalmetteguerinbcgenhancesmonocyteandlymphocytemediatedbladdertumourcellkilling AT goldsteind bacilluscalmetteguerinbcgenhancesmonocyteandlymphocytemediatedbladdertumourcellkilling AT strickerp bacilluscalmetteguerinbcgenhancesmonocyteandlymphocytemediatedbladdertumourcellkilling AT russellp bacilluscalmetteguerinbcgenhancesmonocyteandlymphocytemediatedbladdertumourcellkilling AT golovskyd bacilluscalmetteguerinbcgenhancesmonocyteandlymphocytemediatedbladdertumourcellkilling AT pennyr bacilluscalmetteguerinbcgenhancesmonocyteandlymphocytemediatedbladdertumourcellkilling |